Correlation Between Abnova Taiwan and Synmosa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abnova Taiwan and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abnova Taiwan and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abnova Taiwan Corp and Synmosa Biopharma, you can compare the effects of market volatilities on Abnova Taiwan and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abnova Taiwan with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abnova Taiwan and Synmosa Biopharma.

Diversification Opportunities for Abnova Taiwan and Synmosa Biopharma

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Abnova and Synmosa is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Abnova Taiwan Corp and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Abnova Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abnova Taiwan Corp are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Abnova Taiwan i.e., Abnova Taiwan and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Abnova Taiwan and Synmosa Biopharma

Assuming the 90 days trading horizon Abnova Taiwan Corp is expected to under-perform the Synmosa Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Abnova Taiwan Corp is 1.04 times less risky than Synmosa Biopharma. The stock trades about -0.21 of its potential returns per unit of risk. The Synmosa Biopharma is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  3,345  in Synmosa Biopharma on November 30, 2024 and sell it today you would lose (75.00) from holding Synmosa Biopharma or give up 2.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Abnova Taiwan Corp  vs.  Synmosa Biopharma

 Performance 
       Timeline  
Abnova Taiwan Corp 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Abnova Taiwan Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Abnova Taiwan may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Synmosa Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Synmosa Biopharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Abnova Taiwan and Synmosa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abnova Taiwan and Synmosa Biopharma

The main advantage of trading using opposite Abnova Taiwan and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abnova Taiwan position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.
The idea behind Abnova Taiwan Corp and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years